Status:
WITHDRAWN
Exercise Regimens and Neoadjuvant Chemotherapy
Lead Sponsor:
University of Texas Southwestern Medical Center
Conditions:
Cancer of Gastrointestinal Tract
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
The purpose of this study is to assess the effectiveness of exercise therapy for patients undergoing neoadjuvant chemotherapy for primary gastrointestinal (GI) tract cancer, providing a reproducible e...
Detailed Description
After being informed about the study and potential risks and benefits, all patients meeting inclusion criteria who provide written informed consent will be randomized at the time of enrollment to one ...
Eligibility Criteria
Inclusion
- 18 to 75 years of age
- Primary language is either English or Spanish
- Primary cancer diagnosis of GI cancer
- Undergoing neoadjuvant chemotherapy prior to surgical resection.
- Patients are being treated by medical oncologist at Simmons Cancer Center at Moncrief Cancer Institute in Fort Worth
Exclusion
- Patient has had systemic cancer treatment in the past year
- Patient initiated neoadjuvant chemotherapy treatment prior to study enrollment
Key Trial Info
Start Date :
April 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2023
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04685759
Start Date
April 1 2022
End Date
January 1 2023
Last Update
April 4 2022
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
UT Southwestern Medical Center, Moncrief Cancer Institute
Fort Worth, Texas, United States, 76104
2
UT Southwestern Simmons Comprehensive Cancer Center - Fort Worth
Fort Worth, Texas, United States, 76104